Adicet Bio, Inc. (0HX7.L) LSE

0.57

+0.02832(+5.24%)

Updated at December 04 07:14PM

Currency In USD

Valuation

Market Cap77.65M
Enterprise Value38.39M
P/E Ratio-0.43
PEG Ratio0.55
Price/Sales Ratio7.1
Price/Book Ratio0.38
Enterprise/Revenue4.13
Enterprise/EBITDA-0.23

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-18.23
Operating Margin-19.39

Management Effectiveness

Return On Assets-0.73
Return On Equity-0.68

Income Statement

Revenue0
Revenue/Share0.07
Gross Profit-6.47M
EBITDA-110.65M
Net Income-117.12M
Diluted EPS-1.33

Balance Sheet

Total Cash103.1M
Total Cash/Share1.37
Total Debt15.54M
Total Debt/Equity0.12
Current Ratio7.48
Book Value Per Share1.46

Price History

52-Week Change-42.08
52-Week High7.6
52-Week Low0.54
Moving Average 50 Days2.63
Moving Average 200 Days2.95

Statistics

Average Volume6,355
Shares Outstanding83.28M
% Held by Institutions27.17

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:7
Last Split DateJanuary 08, 2021